ELEV Market Cap History Table | ||||||||||||||||||||||||
Also see: ELEV Shares Outstanding History and ELEV YTD Return |
ELEV Market Cap History Table | ||||||||||||||||||||||||
Also see: ELEV Shares Outstanding History and ELEV YTD Return |
ELEV Market Cap History Chart | |||||||||||||||||||||||||||||||||
-2.53% CAGR Mouse over chart for data details
|
ELEV Stock Price Chart |
About Elevation Oncology Inc |
Elevation Oncology is a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Co.'s primary drug development candidate, seribantumab, is an Anti-HER3 monoclonal antibody and potential targeted therapy for solid tumors driven by neuregulin-1, a type of genomic alteration and oncogenic driver, and other receptor tyrosine-protein kinase erbB- (HER3), genomically defined cancers. Co. is also evaluating opportunities for pipeline expansion including prioritizing additional targeted therapy approaches in tumor types defined by genomic driver alterations. We show 11 historical shares outstanding datapoints in our ELEV shares outstanding history coverage, used to compute ELEV market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ELEV market cap history over the course of time is important for investors interested in comparing ELEV's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ELEV versus a peer is one thing; comparing ELEV market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ELEV can fluctuate over the course of history. With this page we aim to empower investors researching ELEV by allowing them to research the ELEV market cap history. |
ELEV Current Stock Quote |
Free ELEV Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
ELEV Share Performance |
Market Cap Peers |
Elevation Oncology (ELEV) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ELGX Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.